🎗️ OncologyTablet
Truqap
Capivasertib
AKT inhibitor for HR-positive, HER2-negative advanced breast cancer with AKT/PIK3CA/PTEN alterations.
Form
Tablet
Uses
1
Side effects
6
Category
Oncology
01
What is Truqap used for?
- HR+/HER2- advanced breast cancer (with fulvestrant)
02
Capivasertib side effects
The following side effects have been reported for Capivasertib. Their order does not indicate how often an effect occurs.
Diarrhea
Rash
Nausea
Hyperglycemia
Fatigue
Stomatitis
03
Capivasertib warnings & precautions
- Hyperglycemia management required
- Rash management may require dose modification
- Embryo-fetal toxicity
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Truqap in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.